194 related articles for article (PubMed ID: 23261390)
1. P-glycoprotein is fully active after multiple tryptophan substitutions.
Swartz DJ; Weber J; Urbatsch IL
Biochim Biophys Acta; 2013 Mar; 1828(3):1159-68. PubMed ID: 23261390
[TBL] [Abstract][Full Text] [Related]
2. Replacing the eleven native tryptophans by directed evolution produces an active P-glycoprotein with site-specific, non-conservative substitutions.
Swartz DJ; Singh A; Sok N; Thomas JN; Weber J; Urbatsch IL
Sci Rep; 2020 Feb; 10(1):3224. PubMed ID: 32081894
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of a tryptophan-less P-glycoprotein: a tool for tryptophan insertion and fluorescence spectroscopy.
Kwan T; Loughrey H; Brault M; Gruenheid S; Urbatsch IL; Senior AE; Gros P
Mol Pharmacol; 2000 Jul; 58(1):37-47. PubMed ID: 10860925
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressant target protein FKBP12 is required for P-glycoprotein function in yeast.
Hemenway CS; Heitman J
J Biol Chem; 1996 Aug; 271(31):18527-34. PubMed ID: 8702500
[TBL] [Abstract][Full Text] [Related]
5. Multiple transport-active binding sites are available for a single substrate on human P-glycoprotein (ABCB1).
Chufan EE; Kapoor K; Sim HM; Singh S; Talele TT; Durell SR; Ambudkar SV
PLoS One; 2013; 8(12):e82463. PubMed ID: 24349290
[TBL] [Abstract][Full Text] [Related]
6. Functional characterization of a glycine 185-to-valine substitution in human P-glycoprotein by using a vaccinia-based transient expression system.
Ramachandra M; Ambudkar SV; Gottesman MM; Pastan I; Hrycyna CA
Mol Biol Cell; 1996 Oct; 7(10):1485-98. PubMed ID: 8898356
[TBL] [Abstract][Full Text] [Related]
7. Nucleotide-induced conformational changes in P-glycoprotein and in nucleotide binding site mutants monitored by trypsin sensitivity.
Julien M; Gros P
Biochemistry; 2000 Apr; 39(15):4559-68. PubMed ID: 10758006
[TBL] [Abstract][Full Text] [Related]
8. Transition state analysis of the coupling of drug transport to ATP hydrolysis by P-glycoprotein.
Al-Shawi MK; Polar MK; Omote H; Figler RA
J Biol Chem; 2003 Dec; 278(52):52629-40. PubMed ID: 14551217
[TBL] [Abstract][Full Text] [Related]
9. Directed evolution of P-glycoprotein cysteines reveals site-specific, non-conservative substitutions that preserve multidrug resistance.
Swartz DJ; Mok L; Botta SK; Singh A; Altenberg GA; Urbatsch IL
Biosci Rep; 2014 Jun; 34(3):. PubMed ID: 24825346
[TBL] [Abstract][Full Text] [Related]
10. A gene optimization strategy that enhances production of fully functional P-glycoprotein in Pichia pastoris.
Bai J; Swartz DJ; Protasevich II; Brouillette CG; Harrell PM; Hildebrandt E; Gasser B; Mattanovich D; Ward A; Chang G; Urbatsch IL
PLoS One; 2011; 6(8):e22577. PubMed ID: 21826197
[TBL] [Abstract][Full Text] [Related]
11. Effect of modulators on the ATPase activity and vanadate nucleotide trapping of human P-glycoprotein.
Shepard RL; Winter MA; Hsaio SC; Pearce HL; Beck WT; Dantzig AH
Biochem Pharmacol; 1998 Sep; 56(6):719-27. PubMed ID: 9751076
[TBL] [Abstract][Full Text] [Related]
12. Allosteric modulation of human P-glycoprotein. Inhibition of transport by preventing substrate translocation and dissociation.
Maki N; Hafkemeyer P; Dey S
J Biol Chem; 2003 May; 278(20):18132-9. PubMed ID: 12642584
[TBL] [Abstract][Full Text] [Related]
13. Human P-glycoprotein contains a greasy ball-and-socket joint at the second transmission interface.
Loo TW; Bartlett MC; Clarke DM
J Biol Chem; 2013 Jul; 288(28):20326-33. PubMed ID: 23733192
[TBL] [Abstract][Full Text] [Related]
14. Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophore as revealed by its ATPase activity.
Borgnia MJ; Eytan GD; Assaraf YG
J Biol Chem; 1996 Feb; 271(6):3163-71. PubMed ID: 8621716
[TBL] [Abstract][Full Text] [Related]
15. Activation of the human P-glycoprotein ATPase by trypsin.
Nuti SL; Mehdi A; Rao US
Biochemistry; 2000 Mar; 39(12):3424-32. PubMed ID: 10727237
[TBL] [Abstract][Full Text] [Related]
16. Simple purification of highly active biotinylated P-glycoprotein: enantiomer-specific modulation of drug-stimulated ATPase activity.
Julien M; Kajiji S; Kaback RH; Gros P
Biochemistry; 2000 Jan; 39(1):75-85. PubMed ID: 10625481
[TBL] [Abstract][Full Text] [Related]
17. Functional expression of P-glycoprotein in Saccharomyces cerevisiae confers cellular resistance to the immunosuppressive and antifungal agent FK520.
Raymond M; Ruetz S; Thomas DY; Gros P
Mol Cell Biol; 1994 Jan; 14(1):277-86. PubMed ID: 7505392
[TBL] [Abstract][Full Text] [Related]
18. Real-time monitoring of P-glycoprotein activation in living cells.
Landwojtowicz E; Nervi P; Seelig A
Biochemistry; 2002 Jun; 41(25):8050-7. PubMed ID: 12069596
[TBL] [Abstract][Full Text] [Related]
19. Coordinate changes in drug resistance and drug-induced conformational transitions in altered-function mutants of the multidrug transporter P-glycoprotein.
Ruth A; Stein WD; Rose E; Roninson IB
Biochemistry; 2001 Apr; 40(14):4332-9. PubMed ID: 11284689
[TBL] [Abstract][Full Text] [Related]
20. A conserved interdomain communication pathway of pseudosymmetrically distributed residues affects substrate specificity of the fungal multidrug transporter Cdr1p.
Kolaczkowski M; Sroda-Pomianek K; Kolaczkowska A; Michalak K
Biochim Biophys Acta; 2013 Feb; 1828(2):479-90. PubMed ID: 23122779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
